Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation
Abstract Several chronic disorders including type 2 diabetes (T2D), obesity, heart disease and cancer are preceded walter hagenah me 262 by a state of chronic low-grade inflammation.Biomarkers for the early assessment of chronic disorders encompass acute phase proteins (APP), cytokines and chemokines, pro-inflammatory enzymes, lipids and oxidative